Teita Asano

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Top Venues

Drugs - real world outcomes

Crohn's & colitis 360

British journal of pharmacology

Modern rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiko Miyashiro, Teita Asano, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu, Junya Masuda
Treatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort Study. Drugs - real world outcomes (2024)
Masahiko Miyashiro, Teita Asano, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu, Junya Masuda
Treatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort Study. Drugs - real world outcomes 11 (2) (2024)
Masahiko Miyashiro, Teita Asano, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu, Junya Masuda
Treatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort Study. Drugs - real world outcomes 11 (2) (2024)
Katsumasa Nagano, Hiroaki Tsuchiya, Teita Asano, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
Safety and Effectiveness of Ustekinumab for Crohn's Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan. Crohn's & colitis 360 6 (2) (2024)
Katsumasa Nagano, Hiroaki Tsuchiya, Teita Asano, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
Safety and Effectiveness of Ustekinumab for Crohn's Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan. Crohn's & colitis 360 6 (2) (2024)
Teita Asano, Yutaka Ishii, Hiroaki Tsuchiya, Junya Masuda
Efficacy of Golimumab in Rheumatoid Arthritis Patients at High Risk of a Poor Prognosis: Post-Hoc Analysis of GO-FORTH Study using Cluster Analysis. Modern rheumatology (2024)
Masahiko Miyashiro, Teita Asano, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu, Junya Masuda
Treatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort Study. Drugs - real world outcomes 11 (2) (2024)
Teita Asano, Ken-Ichiro Tanaka, Arisa Tada, Hikaru Shimamura, Rikako Tanaka, Hiroki Maruoka, Tohru Mizushima, Mitsuko Takenaga
Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor. British journal of pharmacology 174 (19) (2017)